2020 官网升级中!现在您访问官网的浏览器设备分辨率宽度低于1280px
请使用高分辨率宽度访问。

PRODUCTS

We develop and manufacture medicines of the highest quality

Scrllo Down

View Products

Anbainuo® Recombinant human type II tumor necrosis factor receptor-antibody fusion protein

Indications

Rheumatoid arthritis, ankylosing spondylitis, psoriasis

Product Summary

  • Fusion protein against Tumor Necrosis Factor alpha

  • First approval in China in 2015

  • In-house developed by BioRay / Hisun Pharmaceuticals

  • Numerous post-marketing studies on-going

Learn More

To Learn More

CONTACT US

TO TOP